
AGM
The 2020 Annual General Meeting (AGM) of Allergy Therapeutics plc is due to be held electronically on Tuesday 8 December 2020 at 2:00 p.m. The Board is arranging a listen-only conference call facility to allow shareholders to dial in to the AGM and follow proceedings remotely.
Dial in to the conference callLatest Reports 
Results,Reports And Presentations 
+7% Revenue growth at constant (and 6% at reported rate)
25% Increase in pre-R&D operating profit to £14.2m (2019: £11.3m)
£37.0m Strong cash balance at 30 June 2020 (2019: £27.4m)
£7.1m Net profit for the year including one-off legal settlement of £3.2m (2019: £3.5m)

Our year in numbers
2020 was another year of growth, with a record level of pre R&D operating profit (25%) supported by robust sales and operational efficiencies.
Annual Report 2020